Wegovy (semaglutide 2.4 mg) is a prescription weight management medicine available privately in the UK through services like YourPharmacy. Understanding YourPharmacy Wegovy cost is essential for patients considering this treatment, as monthly expenses typically range from £199 to £249, representing a significant financial commitment. This article examines current pricing at YourPharmacy, compares NHS versus private prescription costs, details what the service includes, and explores practical strategies to reduce treatment expenses whilst maintaining safe, clinically supervised care.

Wegovy Cost at YourPharmacy: Current UK Pricing

Wegovy (semaglutide 2.4 mg) is a prescription-only medicine licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities. As a private pharmacy service, YourPharmacy offers Wegovy through online consultations with registered prescribers, providing an alternative for patients who do not meet NHS eligibility criteria or face waiting times.

The cost of Wegovy at YourPharmacy typically ranges from £199 to £249 per month, depending on the dosage tier and any promotional offers available at the time of purchase. This price includes the medication supply for a four-week period, covering four single-dose pre-filled pens (one pen used per week). Patients should note that Wegovy requires a gradual dose escalation over 16 weeks, starting at 0.25 mg weekly and increasing to the maintenance dose of 2.4 mg weekly (or 1.7 mg if 2.4 mg is not tolerated). The monthly cost remains relatively consistent across dose escalation phases, though some providers may offer introductory pricing for the lower starting doses.

It is important to understand that Wegovy is typically a long-term treatment, with clinical trials demonstrating weight loss results over 68-104 weeks when used alongside lifestyle modifications. The annual cost of private Wegovy treatment can therefore range from approximately £2,400 to £3,000, representing a significant financial commitment. Patients should factor in additional costs such as initial consultation fees (typically £20–£50), follow-up appointments, and potential blood tests or health monitoring required by the prescribing clinician. YourPharmacy provides pricing information during the online consultation process, allowing patients to make informed decisions about treatment affordability before committing to a prescription. Note that prices may vary over time and with supply availability.

NHS vs Private Prescription Costs for Wegovy

The cost difference between NHS and private prescriptions for Wegovy is substantial, though access via the NHS remains highly restricted. Under current NICE guidance (TA875), Wegovy is recommended only for adults with a BMI of ≥35 kg/m² (or ≥32.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds) who have at least one weight-related comorbidity and have participated in a specialist weight management service. NHS treatment is limited to a maximum of 2 years. Even when eligible, NHS availability is limited due to supply constraints and the controlled roll-out by NHS England.

For those who qualify for NHS treatment, the standard prescription charge applies—currently £9.90 per item in England (correct as of April 2023; prescriptions are free in Scotland, Wales, and Northern Ireland). This represents exceptional value compared to private costs, as the NHS absorbs the substantial medication cost. However, patients may wait many months to access NHS specialist weight management services due to overwhelming demand and limited drug supply from the manufacturer, Novo Nordisk.

Private prescriptions through services like YourPharmacy may offer access following a clinical assessment, subject to supply availability and clinical suitability. The trade-off is the significantly higher out-of-pocket cost of £200+ monthly versus the NHS prescription charge. Patients should consider whether they meet NHS criteria and whether their local area offers the service before opting for private treatment. Those with prescription prepayment certificates or exemptions should explore NHS routes first, as the annual cost difference can exceed £2,800. Private treatment may be most appropriate for patients who do not meet NHS eligibility criteria, require intervention for health reasons, or live in areas where NHS provision is unavailable.

YourPharmacy Wegovy Service: What's Included

YourPharmacy provides a comprehensive private weight management service that extends beyond simply dispensing medication. The service begins with an online medical consultation where patients complete a detailed health questionnaire covering medical history, current medications, weight loss goals, and any contraindications to semaglutide therapy. This assessment is reviewed by a UK-registered prescriber (such as a GMC-registered doctor, GPhC pharmacist independent prescriber, or NMC nurse independent prescriber) who determines clinical suitability based on the UK-licensed indication and NICE guidance.

If approved, the monthly Wegovy package includes four single-dose pre-filled pens (one pen used per week), delivered to the patient's home address via tracked courier. The medication is stored and transported under appropriate temperature-controlled conditions to maintain pharmaceutical integrity, as semaglutide requires refrigeration before first use. YourPharmacy also provides patient information leaflets, injection technique guidance, and access to customer support for any queries regarding administration or side effects.

An important component of the service is ongoing clinical monitoring and follow-up consultations. Patients typically have access to their prescriber for questions or concerns, with regular check-ins to assess treatment response, tolerability, and weight loss progress. Treatment continuation is evaluated based on weight loss achieved after a defined period, in line with NICE guidance and the product licence. Some providers include blood pressure monitoring, HbA1c testing for patients with diabetes, and lipid profile assessments as part of comprehensive care.

YourPharmacy may also offer lifestyle support resources, including dietary guidance, physical activity recommendations, and behavioural strategies to optimise weight loss outcomes. While the extent of these additional services varies between providers, reputable pharmacies recognise that pharmacotherapy alone is insufficient—Wegovy should always be prescribed as an adjunct to a reduced-calorie diet and increased physical activity, as demonstrated in the STEP clinical trials.

Important safety information: Wegovy is contraindicated in pregnancy and breastfeeding; effective contraception should be used during treatment and for at least 2 months after discontinuation. Patients should seek urgent medical attention for severe abdominal pain (possible pancreatitis) or signs of gallstones. People with diabetes may require additional retinopathy monitoring. Patients should report suspected side effects via the MHRA Yellow Card scheme.

Ways to Reduce Wegovy Costs in the UK

Given the substantial cost of private Wegovy treatment, patients should explore several strategies to minimise financial burden while maintaining safe, effective care. The most significant saving opportunity is accessing NHS provision if eligible. Patients should request referral to specialist weight management services through their GP, particularly if they meet NICE criteria. While waiting times can be considerable, the cost saving of over £2,500 annually makes this worthwhile for many patients. Some areas offer tier 3 weight management programmes that may eventually provide access to Wegovy or alternative GLP-1 receptor agonists.

Comparing prices across different private providers can yield savings of £30–£50 per month. Reputable online pharmacies, high-street chains with private prescription services, and specialist weight management clinics all offer Wegovy at varying price points. Patients should verify that any provider is registered with the General Pharmaceutical Council (GPhC), the Care Quality Commission (CQC) for online clinical services, and employs appropriately registered prescribers. Be cautious of prices significantly below market rates, as these may indicate unregulated sources or counterfeit medication—a concern highlighted by MHRA safety alerts.

Some private providers offer subscription models or bulk-purchase discounts for patients committing to 3–6 months of treatment upfront. While this requires larger initial outlay, monthly costs may reduce by 10–15%. Additionally, patients should enquire about price-matching policies or promotional offers, particularly during initial consultations. However, never compromise on clinical safety or prescriber qualifications solely to access cheaper medication.

Patients might also consider private medical insurance coverage, though most UK policies currently exclude weight management medications. It is worth checking policy terms directly with your insurer, particularly for patients with documented obesity-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Finally, patients should discuss treatment duration realistically with their prescriber—clinical evidence shows that weight regain commonly occurs after discontinuation, so long-term planning is important when considering the overall cost of treatment.

Frequently Asked Questions